Sign in

Journal of Cellular & Molecular Anesthesia

e-ISSN 2476-5120
p-ISSN 2538-2462
Authors GuideSubmit manuscript

Outline

https://doi.org/10.22037/jcma.v5i3.30630

Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm

Authors

Omid Moradi1,*, Seyed pouzhia Shojaei2, Mehran KouchekMehran Kouchek ORCID2, MirMohammad Miri2, Sara SalarianSara Salarian ORCID2, Mohammad SistanizadMohammad Sistanizad ORCID1
1Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2Critical Care Medicine Ward, Anesthesiology Department, Imam Hossein (A.S.) Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
*Corresponding Author: Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]
Journal of Cellular & Molecular Anesthesia:Vol. 5, issue 3; e150187
Published online:Jul 23, 2020
Article type:Letter to the Editor
How to Cite:Moradi O, Shojaei SP, Kouchek M, Miri M, Salarian S, et al. Interleukin-1 Receptor Antagonist in the Treatment of COVID-19 Induced Cytokine Storm. J Cell Mol Anesth. 2020;5(3):e150187. doi: https://doi.org/10.22037/jcma.v5i3.30630
KeywordsCOVID-19SARS-CoV-2Cytokine StormInterleukin-1AnakinraCritically ill.

References

  • 1.
    References are in the PDF file of the article.

Copyright

© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Oct
2020

Role of IL-4 in Cytokine Storm Syndrome due to COVID-19 Infection

Rahim Soleimani Gelodar,
Sepideh Nasimzadeh,
Amin Dehghan Banadkouki,
milad zandi
PDF

Soleimani Gelodar R, Nasimzadeh S, Dehghan Banadkouki A, zandi M. Role of IL-4 in Cytokine Storm Syndrome due to COVID-19 Infection. J Cell Mol Anesth. 2020;5(4):e149656. doi: https://doi.org/10.22037/jcma.v5i4.32344

18
Nov
2021
High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity

High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity

Didem Ozgür,
Murat Karamese,
Alpay Medetalibeyoglu,
Onur Alkan,
Naci Senkal,
Emin Ediz Tutuncu
PDF

Ozgür D, Karamese M, Medetalibeyoglu A, Alkan O, Senkal N, et al. High Levels of Circulating IL-6 and IL-8 Signature Can Predict COVID-19 Severity. Jundishapur J Microbiol. 2021;14(10):e119060. doi: https://doi.org/10.5812/jjm.119060

5
Jul
2021
Overview of SARS-CoV-2 Infection and Its Potential Reactions

Overview of SARS-CoV-2 Infection and Its Potential Reactions

Esmaeil Mortaz,
Neda K. Dezfuli
PDF

Mortaz E, K. Dezfuli N. Overview of SARS-CoV-2 Infection and Its Potential Reactions. J Adv Immunopharmacol. 2021;1(2):e115161. doi: https://doi.org/10.5812/tms.115161

9
Aug
2021

Inflammatory Rebound in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Mehrdad Farrokhnia,
Behnam Dalfardi
PDF

Farrokhnia M, Dalfardi B. Inflammatory Rebound in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Shiraz E-Med J. 2021;24(1):e115220. doi: https://doi.org/10.5812/semj.115220

4
Dec
2020

Can COVID-19 Be a risk factor for tuberculosis? COVID-19 and tuberculosis

Benyamin Parseh,
ehsan allah kalteh,
Mahnaz Sheikhi,
Mousa Ghelichi-Ghojogh
PDF

Parseh B, kalteh EA, Sheikhi M, Ghelichi-Ghojogh M. Can COVID-19 Be a risk factor for tuberculosis? COVID-19 and tuberculosis. J Cell Mol Anesth. 2021;6(1):e149662. doi: https://doi.org/10.22037/jcma.v6i1.32694

More by these authors

Omid MoradiPubMedScholar
Seyed pouzhia ShojaeiPubMedScholar
Mehran KouchekPubMedScholar
MirMohammad MiriPubMedScholar
Sara SalarianPubMedScholar
Mohammad SistanizadPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF373.46 KB
Import into EndNoteImport into BibTex
Share
Cited by
Metrics
Comments
Number of Comments:0